Stephen Santoro
San Francisco, California, United States
Stephen Santoro is an accomplished immunologist specializing in T cell engineering and molecular biology, with over a decade of experience in immunotherapy and vascular disruption therapy.
He has a track record of designing and assessing T cells with chimeric antigen receptors, demonstrating strong leadership, collaboration, and project management skills.
As a skilled communicator, Stephen excels in public speaking, writing, and interpersonal interactions, making him a valuable asset in both academic and industry environments.
His specialties include Chimeric Antigen Receptors (CARs), Adoptive T-cell Therapy, Immunotherapy, Synthetic Biology, Stromal Immunobiology, Vascular Therapy, and Analytical Chemistry.
Stephen Santoro holds a BA in Molecular, Cellular, and Developmental Biology and Geology from the University of Colorado Boulder, as well as a PhD in Cell and Molecular Biology, Gene Therapy, and Vaccines from the University of Pennsylvania.
He currently serves as a Director at ArsenalBio, with previous roles as Director at Kite Pharma, Senior Scientist and Project Lead at Kite Pharma, Scientist II and Project Lead at Cell Design Labs, and other research positions at Genentech, University of Pennsylvania, and other organizations.
